Atria Wealth Solutions’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$280K Sell
5,800
-10,055
-63% -$514K 0.01% 1191
2025
Q1
$879K Sell
15,855
-1,794
-10% -$97.1K 0.01% 938
2024
Q4
$851K Sell
17,649
-4,298
-20% -$219K 0.01% 996
2024
Q3
$1.26M Buy
21,947
+1,256
+6% +$67.8K 0.01% 829
2024
Q2
$1M Buy
20,691
+1,039
+5% +$50.1K 0.01% 901
2024
Q1
$955K Buy
19,652
+3,282
+20% +$160K 0.01% 928
2023
Q4
$814K Buy
16,370
+1,205
+8% +$58.9K 0.01% 956
2023
Q3
$813K Buy
15,165
+6,847
+82% +$365K 0.01% 908
2023
Q2
$448K Sell
8,318
-2,201
-21% -$118K 0.01% 1211
2023
Q1
$572K Buy
10,519
+5,191
+97% +$252K 0.01% 1054
2022
Q4
$258K Buy
+5,328
New +$234K ﹤0.01% 1444
2022
Q3
Sell
-4,939
Closed -$247K 1846
2022
Q2
$247K Buy
+4,939
New +$262K ﹤0.01% 1324

Other funds holding SNY

Atria Wealth Solutions's SNY Position: Q2 2025 in Review

Atria Wealth Solutions reduced its Sanofi (SNY) stake by 63% in Q2 2025, selling an estimated $514K and leaving 5,800 shares worth $280K. The position accounts for 0.01% of the portfolio, ranked #1191.

Atria Wealth Solutions first reported a position in SNY in Q2 2022 and has held it in 12 quarters since. The position peaked at $1.26M in Q3 2024. 731 funds tracked by Wall St. Rank hold SNY as of Q2 2025.

  • Atria Wealth Solutions held 5,800 shares of Sanofi worth $280K as of Q2 2025.
  • Atria Wealth Solutions sold 10,055 Sanofi shares in Q2 2025, an estimated $514K.
  • Sanofi made up 0.01% of Atria Wealth Solutions's portfolio in Q2 2025, its #1191 holding.
  • Atria Wealth Solutions first reported a position in Sanofi in Q2 2022 and has held it in 12 quarters since.
  • Atria Wealth Solutions's Sanofi position peaked at $1.26M in Q3 2024.
  • 731 funds tracked by Wall St. Rank held Sanofi as of Q2 2025.

Based on Atria Wealth Solutions's 13F filing for Q2 2025, filed 25 Jul 2025.